Drug Interaction Potential
1 clinical trials · Condition
◉ Watch Drug Interaction Potential
| Record | Firm | Date |
|---|---|---|
| Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics) (NCT03291288) | Daiichi Sankyo | 2018-02-26 |
Track Drug Interaction Potential automatically
Every clearance here is in the API, with alerts when new ones post.